Corvus Pharmaceuticals, Inc. CRVS
NASDAQ · United States · Health Technology
$10.93-0.59 (-5.12%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.19 | -0.16 | -19.4% | $0 | — | -0.1%$13.93→$13.92 |
| Q1 2026 | 2026-05-07 | -0.15 | -0.14 | -7.1% | — | — | +0.6%$15.45→$15.55 |
| Q4 2025 | 2026-03-12 | -0.15 | -0.13 | -15.4% | — | — | -9.3%$16.90→$15.32 |
| Q3 2025 | 2025-11-04 | -0.12 | -0.13 | +7.7% | — | — | -2.0%$7.68→$7.53 |
| Q4 2024 | 2025-03-25 | -0.14 | -0.12 | -16.7% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.60 | -0.12 | -400.0% | — | — | — |
| Q2 2024 | 2024-08-06 | -0.07 | -0.11 | +36.4% | — | — | — |
| Q1 2024 | 2024-05-06 | -0.12 | -0.13 | +7.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.